| Literature DB >> 23254652 |
Ricardo Miguel Ferraz Leal1, Gleb Bourenkov, Silvia Russi, Alexander N Popov.
Abstract
The radiation damage rates to crystals of 15 model macromolecular structures were studied using an automated radiation sensitivity characterization procedure. The diffracted intensity variation with dose is described by a two-parameter model. This model includes a strong resolution-independent decay specific to room-temperature measurements along with a linear increase in overall Debye-Waller factors. An equivalent representation of sensitivity via a single parameter, normalized half-dose, is introduced. This parameter varies by an order of magnitude between the different structures studied. The data show a correlation of crystal radiation sensitivity with crystal solvent content but no dose-rate dependency was detected in the range 0.05-300 kGy s(-1). The results of the crystal characterization are suitable for either optimal planning of room-temperature data collection or in situ crystallization plate screening experiments.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23254652 PMCID: PMC3943537 DOI: 10.1107/S0909049512049114
Source DB: PubMed Journal: J Synchrotron Radiat ISSN: 0909-0495 Impact factor: 2.616
Crystallographic parameters, experimental conditions and radiation damage parameter statistics
Ref = Reference. No. = Number of crystals or crystal centerings. Res = Resolution. Ave = average; SD = standard deviation. Dose rate units: kGy s−1. β units: Å2 MGy−1. γ units: MGy−1. units: MGy.
| Unit cell | Space | Solvent content | Res | Dose rate | β | γ |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acronym | Protein | Source | Ref | (Å, °) | group | (%) | No. | (Å) | Min | Max | Ave | SD | Ave | SD | Ave | SD |
| LYZM | Lysozyme | Hen egg-white |
|
|
| 34.0 | 7 | 1.9 | 0.4 | 225 | 15 | 0.5 | 1.0 | 0.2 | 0.56 | 0.07 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| β = 90.2 | ||||||||||||||||
| LYZT | Lysozyme | Hen egg-white |
|
|
| 41.4 | 8 | 1.9 | 15 | 294 | 19 | 4 | 2.0 | 0.3 | 0.32 | 0.03 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| INSR | Insulin | Bovine pancreas |
|
|
| 38.3 | 4 | 2.0 | 10 | 13 | 24 | 3 | 1.0 | 0.3 | 0.47 | 0.06 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| INSC | Insulin | Bovine pancreas |
|
|
| 67.0 | 11 | 2.0 | 0.4 | 87 | 32 | 3 | 3.6 | 0.3 | 0.18 | 0.01 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| BPTTR | Trypsin | Bovine pancreas |
|
|
| 36.5 | 8 | 2.0 | 8 | 40 | 13 | 1 | 1.1 | 0.3 | 0.58 | 0.10 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| BPTOH | Trypsin | Bovine pancreas |
|
|
| 45.0 | 3 | 1.7 | 9.6 | 44 | 14 | 3 | 1.7 | 0.2 | 0.40 | 0.04 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| BPTOL | Trypsin | Bovine pancreas |
|
|
| 56.9 | 10 | 2.2 | 11 | 14.3 | 20 | 4 | 2.8 | 0.4 | 0.24 | 0.03 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| bR | Bacterio-rhodopsin |
|
|
|
| 51.1 | 3 | 3.0 | 1.1 | 124 | 29 | 6 | 1.0 | 0.06 | 0.42 | 0.05 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| TIM | Triosephosphate isomerase |
|
|
|
| 52.1 | 1 | 2.5 | 111 | 33 | – | 1.6 | – | 0.3 | – | |
|
| ||||||||||||||||
|
| ||||||||||||||||
| β = 118 | ||||||||||||||||
| THER | Thermolysin |
|
|
|
| 53.8 | 4 | 2.8 | 17.4 | 20.4 | 28 | 5 | 0.9 | 0.2 | 0.44 | 0.02 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| THAU | Thaumatin |
|
|
|
| 56.8 | 4 | 2.5 | 11 | 16 | 20 | 2 | 1.3 | 0.2 | 0.43 | 0.03 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| FAE | SeMet-FAE |
|
|
|
| 63.3 | 5 | 2.5 | 54 | 79 | 34 | 5 | 1.2 | 0.2 | 0.36 | 0.06 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| 6hlno | 6-hydroxy- |
|
|
|
| 69.7 | 3 | 3.5 | 26.5 | 28 | 215 | 30 | 3.2 | 0.3 | 0.07 | 0.01 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| LACV |
| La Crosse orthobunyavirus |
|
|
| 69.9 | 5 | 3.9 | 27 | 113 | 142 | 20 | 5.7 | 1.0 | 0.08 | 0.003 |
|
| ||||||||||||||||
|
| ||||||||||||||||
| TvNiR | Cytochrome |
|
|
|
| 77.7 | 3 | 2.6 | 30 | 11 | 1 | 0.6 | 0.1 | 0.91 | 0.09 | |
|
| ||||||||||||||||
|
| ||||||||||||||||
Hogle et al. (1981 ▶). Blake et al. (1965 ▶). Smith et al. (2005 ▶). Nanao et al. (2005 ▶). Bode & Huber (1978 ▶). Marquart et al. (1983 ▶). Bartunik et al. (1989 ▶). Borshchevskiy et al. (2011 ▶). Alahuhta & Wierenga (2010 ▶). Mueller-Dieckmann et al. (2007 ▶). Charron et al. (2002 ▶). Prates et al. (2001 ▶). Kachalova et al. (2010 ▶). Reguera et al. (2010 ▶). Boyko et al. (2006 ▶).
Selenomethionine labeled feruloyl esterase module of xylanase 10B.
Figure 1Variation in the scaling parameters and total scattering intensity with dose. For each of the systems studied, one measurement is shown. (a) B-factors: the solid line represents an approximation according to equation (2) using the best fit of B 0 and β. (b) scale factors divided by the constant [equation (3)]: the solid line represents exp(−γ2 D 2) using the best fit value of γ. (c) Total scattered intensity, estimated by intensity summation (dots) and calculated according to equation (4) (solid lines), using the best fit B 0, β and γ as in (a) and (b).
Figure 2A generic empirical model of total diffraction intensity versus resolution, , for B = 10 Å2 (solid line) and B = 20 Å2 (dashed line).
Figure 3Normalized half-dose versus the crystal solvent content. For each of the systems studied, the markers represent the measured values averaged over all experiments performed.
Figure 4Normalized half-dose versus the dose rate for LYZT, LYZM, bR and INSC.